Semax and Selank are two synthetic peptides developed in Russia for cognitive and emotional research. Although they are often discussed together and are frequently combined in research stacks, they have distinct mechanisms and complementary effects. This article breaks down how each works and why researchers study them as a pair.
Semax: A synthetic peptide derived from ACTH(4-7) — a fragment of adrenocorticotropic hormone (ACTH), a stress-response hormone produced by the pituitary gland. Semax is a hexapeptide (6 amino acids).
Selank: A synthetic peptide derived from tuftsin, an immune-modulating fragment originally found in antibodies. Selank is a heptapeptide (7 amino acids). The structure gives it both neurological and immunomodulatory properties.
Primary pathway: Semax drives BDNF (brain-derived neurotrophic factor) upregulation, a protein critical for neuroplasticity, synaptic formation, and long-term memory. It also enhances nerve growth factor (NGF), another key neurotrophin.
Secondary effects:
Behavioral correlates in preclinical research: Enhanced learning, improved memory consolidation, increased motivation and focus, and faster reaction times in animal cognition tests.
Primary pathway: Selank works by GABA and serotonin modulation — it increases inhibitory GABA signaling and serotonin levels, effects that are associated with anxiety reduction and mood stabilization.
Secondary effects:
Behavioral correlates: Reduced anxiety in open-field tests, improved social interaction, faster habituation to novel environments, and normalized sleep patterns in stressed animals.
| Property | Semax | Selank |
|---|---|---|
| Primary effect | Cognitive activation | Anxiety reduction |
| Mechanism | BDNF ↑, dopamine ↑ | GABA ↑, serotonin ↑ |
| Onset | Acute (hours–days) | Acute–gradual (days) |
| Best for | Motivation, focus, learning | Stress resilience, anxiety, sleep |
The reason Semax + Selank is a popular research stack is that they address different neural problems at the same time:
In research terms: Semax opens the accelerator; Selank removes the brake. Most single-compound nootropics can only do one.
In stressed or anxious animal models, Semax alone may not improve cognition because anxiety blocks the cognitive improvements. Selank alone may reduce anxiety but does not enhance motivation or learning speed. Together, they produce synergistic gains in both emotional regulation and cognitive output.
Both Semax and Selank have been extensively studied in Russian and Eastern European research institutions since the 1990s, with hundreds of published studies. However, neither has been approved by the FDA for human use in the United States. They remain classified as research chemicals in the US and are studied in preclinical models and academic research only.
Universe Peptide supplies both Semax (p005) and Selank (p006) for preclinical research into cognition and emotional regulation. HPLC-verified, third-party tested. See more in our News & research updates.